JPWO2020234300A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020234300A5 JPWO2020234300A5 JP2021564088A JP2021564088A JPWO2020234300A5 JP WO2020234300 A5 JPWO2020234300 A5 JP WO2020234300A5 JP 2021564088 A JP2021564088 A JP 2021564088A JP 2021564088 A JP2021564088 A JP 2021564088A JP WO2020234300 A5 JPWO2020234300 A5 JP WO2020234300A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- amino acid
- domain
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175413.4 | 2019-05-20 | ||
| EP19175413 | 2019-05-20 | ||
| PCT/EP2020/063973 WO2020234300A1 (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533318A JP2022533318A (ja) | 2022-07-22 |
| JPWO2020234300A5 true JPWO2020234300A5 (he) | 2023-05-31 |
Family
ID=66685352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564088A Pending JP2022533318A (ja) | 2019-05-20 | 2020-05-19 | 気道感染の治療または予防のためのサブユニットワクチン |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20220185847A1 (he) |
| EP (1) | EP3972639A1 (he) |
| JP (1) | JP2022533318A (he) |
| KR (1) | KR20220010478A (he) |
| CN (1) | CN114127101A (he) |
| AU (1) | AU2020277661A1 (he) |
| BR (1) | BR112021021637A2 (he) |
| CA (1) | CA3138064A1 (he) |
| CL (1) | CL2021002819A1 (he) |
| CO (1) | CO2021014694A2 (he) |
| EC (1) | ECSP21079178A (he) |
| GB (1) | GB2598494B (he) |
| IL (1) | IL287099A (he) |
| MX (1) | MX2021013111A (he) |
| PE (1) | PE20220400A1 (he) |
| SA (1) | SA521430813B1 (he) |
| SG (1) | SG11202110646PA (he) |
| WO (1) | WO2020234300A1 (he) |
| ZA (1) | ZA202106883B (he) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2957939T3 (es) | 2017-04-13 | 2024-01-30 | Valneva Austria Gmbh | Polipéptidos de OspA multivalentes y métodos y usos relacionados con los mismos |
| CA3174599A1 (en) | 2020-04-09 | 2021-10-14 | Robert Schlegl | Improvements in vaccine formulations for medical use |
| PE20231439A1 (es) | 2020-10-09 | 2023-09-14 | Univ Texas | Proteinas f de hmpv estabilizadas por prefusion |
| WO2022103967A1 (en) | 2020-11-13 | 2022-05-19 | Icosavax, Inc. | Protein-based nanoparticle vaccine for metapneumovirus |
| AU2022255923A1 (en) | 2021-04-09 | 2023-08-31 | Valneva Se | Human metapneumo virus vaccine |
| WO2023110618A1 (en) * | 2021-12-16 | 2023-06-22 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
| WO2024154048A1 (en) | 2023-01-18 | 2024-07-25 | Pfizer Inc. | Vaccines against respiratory diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1167377B2 (en) | 1994-07-15 | 2012-08-08 | University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| CN1309418C (zh) | 2000-06-08 | 2007-04-11 | 英特塞尔生物医药研究发展股份公司 | 免疫刺激性寡脱氧核苷酸 |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| WO2002013857A2 (en) | 2000-08-17 | 2002-02-21 | Intercell Biomedizinische Forschungs- Und Entwicklungs Ag | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| US8715922B2 (en) * | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| WO2002094845A2 (en) | 2001-05-21 | 2002-11-28 | Intercell Ag | Method for stabilising of nucleic acids |
| EP1450821A1 (en) | 2001-12-07 | 2004-09-01 | Intercell AG | Immunostimulatory oligodeoxynucleotides |
| ES2562456T3 (es) | 2003-03-24 | 2016-03-04 | Valneva Austria Gmbh | Uso de un adyuvante que induce una respuesta inmune Th1 para mejorar las respuestas inmunes |
| EP2494986A1 (en) * | 2003-04-25 | 2012-09-05 | MedImmune Vaccines, Inc. | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| CN102145167A (zh) * | 2010-02-05 | 2011-08-10 | 重庆医科大学附属儿童医院 | 重组人类偏肺病毒疫苗 |
| DK2788023T3 (en) | 2011-12-06 | 2016-12-19 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| WO2016103238A1 (en) | 2014-12-24 | 2016-06-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Recombinant metapneumovirus f proteins and their use |
| WO2019092002A1 (en) * | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
-
2020
- 2020-05-19 CA CA3138064A patent/CA3138064A1/en active Pending
- 2020-05-19 KR KR1020217034461A patent/KR20220010478A/ko unknown
- 2020-05-19 BR BR112021021637A patent/BR112021021637A2/pt unknown
- 2020-05-19 GB GB2114836.6A patent/GB2598494B/en active Active
- 2020-05-19 US US17/606,811 patent/US20220185847A1/en active Pending
- 2020-05-19 PE PE2021001766A patent/PE20220400A1/es unknown
- 2020-05-19 EP EP20726137.1A patent/EP3972639A1/en active Pending
- 2020-05-19 AU AU2020277661A patent/AU2020277661A1/en active Pending
- 2020-05-19 JP JP2021564088A patent/JP2022533318A/ja active Pending
- 2020-05-19 WO PCT/EP2020/063973 patent/WO2020234300A1/en active Application Filing
- 2020-05-19 MX MX2021013111A patent/MX2021013111A/es unknown
- 2020-05-19 SG SG11202110646PA patent/SG11202110646PA/en unknown
- 2020-05-19 CN CN202080030901.9A patent/CN114127101A/zh active Pending
-
2021
- 2021-09-17 ZA ZA2021/06883A patent/ZA202106883B/en unknown
- 2021-10-07 IL IL287099A patent/IL287099A/he unknown
- 2021-10-25 EC ECSENADI202179178A patent/ECSP21079178A/es unknown
- 2021-10-26 CL CL2021002819A patent/CL2021002819A1/es unknown
- 2021-10-29 CO CONC2021/0014694A patent/CO2021014694A2/es unknown
- 2021-11-10 SA SA521430813A patent/SA521430813B1/ar unknown
-
2023
- 2023-10-24 US US18/493,004 patent/US20240067681A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11998597B2 (en) | Vaccine against RSV | |
| GB2598494A (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| ES2258796T3 (es) | Proteinas de fusion que contienen proteinas de estres para inducir respuestas inmunitarias. | |
| EP0276014B1 (en) | Anticoagulant peptides | |
| JP2015512876A5 (he) | ||
| RU2021132097A (ru) | Белки rsv f в предшествующей слиянию конформации и их применение | |
| WO2021249116A9 (en) | Coronavirus vaccine compositions, methods, and uses thereof | |
| NO20025153D0 (no) | FremgangsmÕter og sammensetninger for Õ svekke formering av HIV-1 | |
| JPWO2020234300A5 (he) | ||
| EP0291981B1 (en) | Cyclic anticoagulant peptides | |
| JP2023510864A (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用 | |
| EP0291982B1 (en) | Cyclic anticoagulant peptides | |
| RU2010140443A (ru) | Применение коньюгатов интерлейкина-1 в лечении диабета | |
| WO2021249013A9 (en) | Vaccine compositions, methods, and uses thereof | |
| JP2899430B2 (ja) | 安定化されたヒルディンのスルホネ−ト、サルフェ−ト、ホスホネ−ト、及びホスフェ−ト誘導体 | |
| RU2021128047A (ru) | Субъединичная вакцина для лечения или предотвращения инфекции дыхательных путей | |
| CN1043134A (zh) | 肽类抗凝剂 | |
| EP0468448B1 (en) | Analogs of hirudin having antiplatelet activity | |
| JPWO2019222682A5 (he) | ||
| JPWO2021173879A5 (he) | ||
| MX2024001360A (es) | Antigeno recombinante para la induccion de respuesta inmune contra el virus zika. | |
| RU2020141586A (ru) | Способы лечения гемофилии a | |
| JPWO2020120983A5 (he) | ||
| JPWO2021112235A5 (he) | ||
| JPWO2021046398A5 (he) |